鼓膜穿刺联合地塞米松鼓室注射治疗分泌性中耳炎临床疗效
2016-07-23吴佳丽
吴佳丽
鼓膜穿刺联合地塞米松鼓室注射治疗分泌性中耳炎临床疗效
吴佳丽
【摘要】目的 分析鼓膜穿刺联合地塞米松鼓室注射治疗分泌性中耳炎临床疗效。方法 选取我院分泌性中耳炎患者80例,分为两组,收治时间为2012年5月~2015年9月,对照组采用鼓膜穿刺治疗,观察组采用鼓膜穿刺联合地塞米松鼓室注射治疗。结果 观察组分泌性中耳炎患者治疗后的总有效率优于对照组,观察组分泌性中耳炎患者治疗后的不良反应发生率低于对照组(P<0.05)。结论 给予分泌性中耳炎患者采用联合治疗,能有效提高患者治疗总有效率,减少不良反应发生率。
【关键词】鼓膜穿刺;地塞米松鼓室注射;分泌性中耳炎
Objective To analyze the tympanic membrane tympanic cavity puncture combined dexamethasone injection in the treatment of secretory otitis media clinical curative effect. Methods Selected our hospital 80 cases of secretory otitis media patients,divided into two groups,treated time was from May 2012 to September 2015. The control group used the tympanic membrane puncture treatment,and the observation group was treated with tympanic cavity tympanic membrane puncture in combination with dexamethasone injection. Results Observation group with secretory otitis media of total effective rate was superior to that of the control group,the observation group with secretory otitis media patients with adverse reactions occurred is significantly higher than the control group after treatment(P<0.05). Conclusion Giving secretory otitis media combined treatment,can effectively increase the patients'total effective rate.
【Key words】 Tympanic membrane puncture,Dexamethasone tympanic cavity injection,Secretory otitis media
分泌性中耳炎是临床较为严重且多发的疾病,严重者可导致耳聋[1]。因此,本院选取80例分泌性中耳炎患者分别实施鼓膜穿刺治疗和鼓膜穿刺联合地塞米松鼓室注射治疗,具体的内容见下文描述。
1 资料和方法
1.1基线资料
选取我院分泌性中耳炎患者80例,收治时间为2012年5月~2015年9月,按照抽签随机分组方式,将分泌性中耳炎患者分为两组,40例为观察组,40例为对照组。观察组;20例为男性患者,20例为女性患者,年龄30~60岁,平均年龄为(45.03±1.02)岁,平均病程为(20.11±0.21)周。对照组;19例为男性患者,21例为女性患者,年龄32~60岁,平均年龄为(46.27±1.34)岁,平均病程为(21.33±0.15)周。观察组、对照组两组分泌性中耳炎患者的性别、年龄与病程,各项资料差异无统计学意义(P>0.05),可进行对比。
1.2方法
对照组分泌性中耳炎患者采用鼓膜穿……
